AtaiBeckley (ATAI) Other Non-Current Liabilities (2021 - 2026)

AtaiBeckley's (ATAI) quarterly Other Non-Current Liabilities came in at $104000.0 in Q1 2026, down 86.21% quarter-over-quarter from $754000.0 in Q4 2025.

AtaiBeckley (ATAI) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

AtaiBeckley's Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $104000.0 for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $104000.0 in Q1 2026; TTM through Mar 2026 was $104000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $754000.0, down 72.02% from the prior year.
  • Other Non-Current Liabilities fell to $104000.0 in Q1 2026 per ATAI's latest filing, from $754000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $57.8 million in Q3 2025 to a low of $110000.0 in Q4 2024.
  • A 5-year average of $6.7 million and a median of $3.5 million in 2021 frame the typical range for Other Non-Current Liabilities.
  • Biggest YoY gain for Other Non-Current Liabilities was 72.02% in 2025; the steepest drop was 72.02% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $2.7 million in 2024, then plunged by 72.02% to $754000.0 in 2025, then slumped by 86.21% to $104000.0 in 2026.
  • Per Business Quant, the three latest ATAI Other Non-Current Liabilities figures stand at $104000.0 (Q1 2026), $754000.0 (Q4 2025), and $2.7 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 AtaiBeckley 2.56 Bn 2.56 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 104,000.00
Dec 31, 2025 754,000.00
Sep 30, 2025 57.75 Mn
Jun 30, 2025 3.03 Mn
Mar 31, 2025 110,000.00
Dec 31, 2024 2.70 Mn
Dec 31, 2024 110,000.00
Sep 30, 2024 8.38 Mn
Jun 30, 2024 8.26 Mn
Mar 31, 2024 8.28 Mn
Dec 31, 2023 7.92 Mn
Sep 30, 2023 2.74 Mn
Jun 30, 2023 842,000.00
Mar 31, 2023 918,000.00
Dec 31, 2022 3.66 Mn
Sep 30, 2022 3.70 Mn
Jun 30, 2022 3.90 Mn
Mar 31, 2022 4.13 Mn
Dec 31, 2021 2.43 Mn
Sep 30, 2021 1.95 Mn